WinstonWınston
EssilorLuxottica S.A. logo

EssilorLuxottica S.A.

ESLOY
63
Medical - Instruments & Supplies · Healthcare
Price
$94.81
-4.16 (-4.20%)
Market Cap
$87.15B
Exchange
Other OTC
Winston Score
63
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 13, 2026 · filings through Jun 30, 2026

Share count rising — dilution

+4.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 890.9M (2021) → 929.3M (2025)

EssilorLuxottica is a French-Italian company that makes eyeglass lenses and frames. It owns some of the most recognized eyewear brands in the world, including Ray-Ban, Oakley, and Persol, and also makes the lenses found in glasses sold under the Varilux and Transitions names. It sells to everyday consumers, eye doctors, and optical retailers across the globe.

The company makes money by selling eyewear products directly to consumers through its own retail stores — including LensCrafters and Sunglass Hut — and by supplying lenses and frames to independent opticians and retailers. It operates in over 150 countries, making it the largest eyewear company in the world by a wide margin. Its massive scale, control of both lenses and frames, and ownership of dominant retail chains give it a strong competitive position. The key growth driver is rising global demand for vision correction, especially in emerging markets, though currency swings and integration complexity from its 2018 merger remain ongoing risks.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+13.8% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$638M/ year

Flat (+1% vs prior year)

2.2% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

68.0%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$2.0B cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

EssilorLuxottica S.A. is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
63.5%
Premium pricing power — 63.5% gross margin
Operating Margin
15.2%
Healthy — 15.2% operating margin
ROCE
4.5%
Weak — 4.5% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+8.2%
Steady sales growth (+8.2% YoY)
EPS YoY
+4.6%
Modest earnings growth (+4.6% YoY)

Single-digit earnings growth — steady but not exciting.

EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
216%
Turns 216% of profit into real cash
FCF Margin
13.4%
Converts sales into free cash efficiently (13.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.29
Conservative — low debt load (0.29)
Interest Cover
10.36x
Comfortably covers interest (10.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
34.7x
Pricey — P/E 34.7

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+12.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (34.7 → 22.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.34%
Moderate income — 2.34% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+122.1%
Dividend growing fast (122.1% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial